Microport Cardioflow Medtech Corp
OTC:MROPF
Balance Sheet
Balance Sheet Decomposition
Microport Cardioflow Medtech Corp
Microport Cardioflow Medtech Corp
Balance Sheet
Microport Cardioflow Medtech Corp
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
50
|
109
|
612
|
4 423
|
1 866
|
2 130
|
108
|
|
| Cash |
0
|
0
|
0
|
2 212
|
1 866
|
1 065
|
108
|
|
| Cash Equivalents |
50
|
109
|
612
|
2 212
|
0
|
1 065
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
192
|
209
|
708
|
1 251
|
|
| Total Receivables |
5
|
21
|
26
|
99
|
53
|
133
|
171
|
|
| Accounts Receivables |
0
|
0
|
5
|
75
|
50
|
101
|
137
|
|
| Other Receivables |
5
|
21
|
22
|
24
|
3
|
32
|
34
|
|
| Inventory |
17
|
49
|
68
|
83
|
114
|
123
|
135
|
|
| Other Current Assets |
5
|
4
|
13
|
15
|
30
|
13
|
9
|
|
| Total Current Assets |
77
|
184
|
720
|
2 600
|
2 272
|
2 041
|
1 674
|
|
| PP&E Net |
34
|
43
|
68
|
267
|
242
|
197
|
506
|
|
| PP&E Gross |
34
|
43
|
68
|
267
|
242
|
197
|
506
|
|
| Accumulated Depreciation |
7
|
15
|
25
|
48
|
88
|
134
|
194
|
|
| Intangible Assets |
196
|
222
|
234
|
239
|
163
|
144
|
192
|
|
| Note Receivable |
17
|
9
|
6
|
0
|
0
|
0
|
18
|
|
| Long-Term Investments |
76
|
87
|
84
|
231
|
298
|
167
|
258
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
25
|
26
|
28
|
27
|
|
| Total Assets |
402
N/A
|
546
+36%
|
1 112
+104%
|
3 362
+202%
|
3 001
-11%
|
2 577
-14%
|
2 676
+4%
|
|
| Liabilities | ||||||||
| Accounts Payable |
29
|
23
|
71
|
107
|
87
|
206
|
40
|
|
| Accrued Liabilities |
82
|
13
|
15
|
20
|
28
|
38
|
29
|
|
| Short-Term Debt |
0
|
20
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4
|
7
|
7
|
35
|
31
|
29
|
63
|
|
| Other Current Liabilities |
0
|
325
|
1 338
|
55
|
70
|
74
|
302
|
|
| Total Current Liabilities |
115
|
388
|
1 432
|
164
|
177
|
194
|
434
|
|
| Long-Term Debt |
12
|
11
|
9
|
91
|
64
|
42
|
14
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
34
|
|
| Other Liabilities |
1
|
15
|
17
|
10
|
6
|
7
|
6
|
|
| Total Liabilities |
129
N/A
|
414
+222%
|
1 457
+252%
|
266
-82%
|
248
-7%
|
242
-2%
|
489
+102%
|
|
| Equity | ||||||||
| Common Stock |
13
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
91
|
556
|
910
|
1 117
|
1 673
|
2 136
|
2 313
|
|
| Additional Paid In Capital |
351
|
694
|
482
|
4 151
|
4 164
|
4 171
|
4 172
|
|
| Other Equity |
0
|
6
|
83
|
63
|
263
|
300
|
328
|
|
| Total Equity |
273
N/A
|
132
-52%
|
345
N/A
|
3 096
N/A
|
2 754
-11%
|
2 335
-15%
|
2 187
-6%
|
|
| Total Liabilities & Equity |
402
N/A
|
546
+36%
|
1 112
+104%
|
3 362
+202%
|
3 001
-11%
|
2 577
-14%
|
2 676
+4%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
2 366
|
2 366
|
2 366
|
2 404
|
2 409
|
2 412
|
2 413
|
|